BlackRock Investment Management’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
$1.63M Sell
134,303
-523
-0.4% -$6.36K ﹤0.01% 2362
2016
Q3
$1.24M Buy
134,826
+5,440
+4% +$50K ﹤0.01% 2513
2016
Q2
$1.23M Buy
129,386
+1,398
+1% +$13.3K ﹤0.01% 2474
2016
Q1
$902K Buy
127,988
+933
+0.7% +$6.58K ﹤0.01% 2550
2015
Q4
$1.33M Buy
127,055
+1,160
+0.9% +$12.1K ﹤0.01% 2380
2015
Q3
$842K Sell
125,895
-3,641
-3% -$24.4K ﹤0.01% 2716
2015
Q2
$870K Buy
129,536
+15,062
+13% +$101K ﹤0.01% 2870
2015
Q1
$776K Sell
114,474
-743
-0.6% -$5.04K ﹤0.01% 2685
2014
Q4
$923K Sell
115,217
-1,852
-2% -$14.8K ﹤0.01% 2596
2014
Q3
$412K Buy
117,069
+3,640
+3% +$12.8K ﹤0.01% 3060
2014
Q2
$542K Buy
113,429
+20,021
+21% +$95.7K ﹤0.01% 2987
2014
Q1
$887K Buy
93,408
+16,642
+22% +$158K ﹤0.01% 2576
2013
Q4
$499K Sell
76,766
-1,204
-2% -$7.83K ﹤0.01% 2935
2013
Q3
$590K Buy
+77,970
New +$590K ﹤0.01% 2808